Concepedia

Herbert H. Schneider

HH

Statistics

Publications

32

Citations

2K

H-Index

25

Active since

1962

Affiliations

TE Laboratories (Ireland)(Current)

Max Planck Institute for Brain Research

Albert Einstein College of Medicine

Freie Universität Berlin

Ferrosan Medical Devices (Denmark)

Herbert H. Schneider is an author at TE Laboratories (Ireland) specializing in pharmacology, neuropharmacology, and medicine.

Publications per year

1962–2005

32

Publications

32

Stereospecific binding of the antidepressant rolipram to brain protein structures

Herbert H. Schneider, Ralph Schmiechen, Marina Brezinski et al. · European Journal of Pharmacology · 1986 · 236 citations

, , +14

ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma

Lechosław Turski, Andreas Huth, Malcolm J. Sheardown et al. · Proceedings of the National Academy of Sciences · 1998 · 168 citations · Full text

, , +16

Evaluation of the ?-carboline ZK 93 426 as a benzodiazepine receptor antagonist

Leif H. Jensen, Erling N. Petersen, Tage Honor� et al. · Psychopharmacology · 1984 · 154 citations

, , +6

Functional Characterization and Comparison of the Outer Blood–Retina Barrier and the Blood–Brain Barrier

Heiko Steuer, Andreas Jaworski, Bernd Elger et al. · Investigative Ophthalmology & Visual Science · 2005 · 147 citations

, , +16

Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.

D.N. Stephens, Herbert H. Schneider, W. Kehr et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 132 citations

, , +14

1–5 of 32